Faculty Publications

Phase I trial of combination therapy with Y-90 ibritumomab tiuxetan and gemcitabine in patients with non-Hodgkin is lymphoma

Borghaei H, Smith M, Millenson M, Shafer D, Thibodeau L, Schilder R

Phase I trial of combination therapy with Y-90 ibritumomab tiuxetan and gemcitabine in patients with non-Hodgkin is lymphoma

Blood. 2006 Nov;108(11):260B-260B.

Abstract

Last updated on Saturday, November 21, 2009